← Open Payments lookup

TODD SEAMONS: Open Payments

NPI 1821125907 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$682 in 36 payments from 21 companies in 2025. Trend: 2023 $1,224 · 2024 $1,325 · 2025 $682

Food & beverage: $682
CompanyPaymentsAmount
ABBVIE INC.9$159
Axsome Therapeutics, Inc.2$61
AstraZeneca Pharmaceuticals LP3$50
Abbott Laboratories1$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Janssen Pharmaceuticals, Inc2$39
Takeda Pharmaceuticals U.S.A., Inc.2$37
Indivior Inc.2$34
Neurocrine BioSciences, Inc.1$24
Corium, LLC1$21

Products named: QULIPTA, VRAYLAR, Auvelity, FREESTYLE LIBRE 3, CAPLYTA, SPRAVATO, TRINTELLIX, AIRSUPRA.

Industry payments across UT — which companies pay providers there.